FourThought Financial Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4M | Buy |
57,934
+50,120
| +641% | +$3.46M | 0.39% | 70 |
|
|
2025
Q1 | $543K | Buy |
7,814
+808
| +12% | +$56.1K | 0.06% | 175 |
|
|
2024
Q4 | $603K | Buy |
7,006
+76
| +1% | +$6.54K | 0.06% | 171 |
|
|
2024
Q3 | $825K | Buy |
6,930
+110
| +2% | +$13.1K | 0.1% | 117 |
|
|
2024
Q2 | $973K | Sell |
6,820
-56
| -0.8% | -$7.99K | 0.13% | 108 |
|
|
2024
Q1 | $883K | Buy |
6,876
+1,413
| +26% | +$181K | 0.1% | 146 |
|
|
2023
Q4 | $565K | Sell |
5,463
-98
| -2% | -$10.1K | 0.07% | 183 |
|
|
2023
Q3 | $506K | Sell |
5,561
-115
| -2% | -$10.5K | 0.07% | 182 |
|
|
2023
Q2 | $459K | Sell |
5,676
-1,574
| -22% | -$127K | 0.06% | 201 |
|
|
2023
Q1 | $577K | Sell |
7,250
-306
| -4% | -$24.4K | 0.08% | 166 |
|
|
2022
Q4 | $511K | Buy |
+7,556
| New | +$511K | 0.07% | 180 |
|